Clinical Trial Update: Role of Hemostatic Powder (Endo-clotTM) in Success and Prevention of Bleeding Within Gastric Cancer Patients With Bleeding [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating Endo-clot hemostatic powder for stopping and preventing bleeding in gastric cancer patients with bleeding.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Endo-clotTM

Snippet

Sponsor: Yonsei University | Conditions: Bleeding at Gastric Cancer | Phase 2 | Status: UNKNOWN